The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue SUPPL. 1, 2006, Pages

  Antzelevitch, Charles ^a   Belardinelli, Luiz ^b  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b CV THERAPEUTICS INC   (United States)

Author keywords

Brugada syndrome; Cardiac heterogeneity; Electrocardiogram; Long QT syndrome; M cell

Indexed keywords

SODIUM CHANNEL; TOXIN;

ARRHYTHMOGENESIS; BRUGADA SYNDROME; CELL TYPE; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOCARDIUM; EPICARDIUM; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HEART VENTRICLE TACHYCARDIA; ION CURRENT; MAMMAL; MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QT PROLONGATION; REENTRY ARRHYTHMIA; SODIUM CURRENT; T WAVE; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIA; BIOLOGICAL CLOCKS; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNEL GATING; MEMBRANE POTENTIALS; MODELS, CARDIOVASCULAR; SODIUM; SODIUM CHANNELS;

EID: 33645997040     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00388.x     Document Type: Conference Paper

References (68)

1. Antzelevitch C Dumaine R Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications. In Page E Fozzard HA Solaro RJ eds. Handbook of Physiology. Section 2 The Cardiovascular System. New York Oxford University Press 2001 pp. 654 692.
2. to and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 1996 271 H548 H561.
3. Volders PG Sipido KR Carmeliet E Spatjens RL Wellens HJ Vos MA Repolarizing K+ currents ITO1 and IKs are larger in right than left canine ventricular midmyocardium. Circulation 1999 99 2 206 210.
4. Sicouri S Antzelevitch C A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 1991 68 1729 1741.
5. Antzelevitch C Shimizu W Yan GX Sicouri S Weissenburger J Nesterenko VV Burashnikov A Di Diego JM Saffitz JE Thomas GP The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999 10 8 1124 1152.
6. Anyukhovsky EP Sosunov EA Gainullin RZ Rosen MR The controversial M cell. J Cardiovasc Electrophysiol 1999 10 244 260.
7. Sicouri S Fish J Antzelevitch C Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 1994 5 824 837.
8. Yan GX Shimizu W Antzelevitch C Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations. Circulation 1998 98 1921 1927.
9. Poelzing S Akar FG Baron E Rosenbaum DS Heterogeneous connexin43 expression produces electrophysiological heterogeneities across ventricular wall. Am J Physiol Heart Circ Physiol 2004 286 5 H2001 H2009.
10. Yamada KA Kanter EM Green KG Saffitz JE Transmural distribution of connexins in rodent hearts. J Cardiovasc Electrophysiol 2004 15 6 710 715.
11. Zygmunt AC Eddlestone GT Thomas GP Nesterenko VV Antzelevitch C Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol 2001 281 H689 H697.
12. Liu DW Antzelevitch C Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. Circ Res 1995 76 351 365.
13. Na-Ca contributes to electrical heterogeneity within the canine ventricle. Am J Physiol 2000 278 H1671 H1678.
14. Yan GX Antzelevitch C Cellular basis for the electrocardiographic J wave. Circulation 1996 93 372 379.
15. Yan GX Antzelevitch C Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998 98 1928 1936.
16. Schwartz PJ The idiopathic long QT syndrome: Progress and questions. Am Heart J 1985 109 399 411.
17. Moss AJ Schwartz PJ Crampton RS Tzivoni D Locati EH MacCluer JW Hall WJ Weitkamp LR Vincent GM Garson A Robinson JL Benhorin J Choi S The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991 84 1136 1144.
18. Zipes DP The long QT interval syndrome: A Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991 84 1414 1419.
19. Wang Q Shen J Splawski I Atkinson DL Li ZZ Robinson JL Moss AJ Towbin JA Keating MT SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995 80 805 811.
20. Mohler PJ Schott JJ Gramolini AO Dilly KW Guatimosim S duBell WH Song LS Haurogne K Kyndt F Ali ME Rogers TB Lederer WJ Escande D Le Marec H Bennett V Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003 421 6923 634 639.
21. Plaster NM Tawil R Tristani-Firouzi M Canun S Bendahhou S Tsunoda A Donaldson MR Iannaccone ST Brunt E Barohn R Clark J Deymeer F George AL Jr. Fish FA Hahn A Nitu A Ozdemir C Serdaroglu P Subramony SH Wolfe G Fu YH Ptacek LJ Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001 105 511 519.
22. Curran ME Splawski I Timothy KW Vincent GM Green ED Keating MT A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995 80 795 803.
23. Wang Q Curran ME Splawski I Burn TC Millholland JM Van Raay TJ Shen J Timothy KW Vincent GM De Jager T Schwartz PJ Towbin JA Moss AJ Atkinson DL Landes GM Connors TD Keating MT Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996 12 17 23.
24. Ks function. Nat Genet 1997 17 338 340.
25. Splawski I Timothy KW Sharpe LM Decher N Kumar P Bloise R Napolitano C Schwartz PJ Joseph RM Condouris K Tager-Flusberg H Priori SG Sanguinetti MC Keating MT Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004 119 1 19 31.
26. Bednar MM Harrigan EP Anziano RJ Camm AJ Ruskin JN The QT interval. Prog Cardiovasc Dis 2001 43 5 Pt 2 1 45.
27. Tomaselli GF Marban E Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999 42 270 283.
28. Sipido KR Volders PG De Groot SH Verdonck F Van de WF Wellens HJ Vos MA Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: Potential link between contractile adaptation and arrhythmogenesis. Circulation 2000 102 17 2137 2144.
29. Volders PG Sipido KR Vos MA Spatjens RL Leunissen JD Carmeliet E Wellens HJ Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999 100 24 2455 2461.
30. Undrovinas AI Maltsev VA Sabbah HN Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: Role of sustained inward current. Cell Mol Life Sci 1999 55 3 494 505.
31. Maltsev VA Sabbah HN Higgins RS Silverman N Lesch M Undrovinas AI Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998 98 23 2545 2552.
32. Antzelevitch C Shimizu W Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 2002 17 1 43 51.
33. Shimizu W Antzelevitch C Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 2000 102 6 706 712.
34. Shimizu W Antzelevitch C Cellular basis for the ECG features of the LQT1 form of the long QT syndrome: Effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998 98 2314 2322.
35. Shimizu W Antzelevitch C Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997 96 2038 2047.
36. Shimizu W Antzelevitch C Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000 35 778 786.
37. Shimizu W Kamakura S Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J Electrocardiol 2001 34 Suppl 173 175.
38. Shimizu W Antzelevitch C Characteristics of spontaneous as well as stimulation-induced torsade de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation 1997 96 I-554 Abstract
39. El-Sherif N Caref EB Chinushi M Restivo M Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome. J Am Coll Cardiol 1999 33 5 1415 1423.
40. Restivo M Caref EB Kozhevnikov DO El-Sherif N Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 2004 15 3 323 331.
41. Milberg P Reinsch N Wasmer K Monnig G Stypmann J Osada N Breithardt G Haverkamp W Eckardt L Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3. Cardiovasc Res 2005 65 2 397 404.
42. Wu L Shryock JC Song Y Li Y Antzelevitch C Belardinelli L Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome. J Pharmacol Exp Ther 2004 310 2 599 605.
43. Song Y Shryock JC Wu L Belardinelli L Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 2004 44 2 192 199.
44. Valdivia CR Chu WW Pu J Foell JD Haworth RA Wolff MR Kamp TJ Makielski JC Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005 38 3 475 483.
45. Ju YK Saint DA Gage PW Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 1996 497 Pt 2 337 347.
46. Ward CA Giles WR Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 1997 500 Pt 3 631 642.
47. Wu J Corr PB Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes. Am J Physiol 1994 266 3 Pt 2 H1034 H1046.
48. Huang B El Sherif T Gidh-Jain M Qin D El-Sherif N Alterations of sodium channel kinetics and gene expression in the postinfarction remodeled myocardium. J Cardiovasc Electrophysiol 2001 12 2 218 225.
49. Antzelevitch C Electrical heterogeneity, cardiac arrhythmias, and the sodium channel [In Process Citation]. Circ Res 2000 87 11 964 965.
50. Antzelevitch C Belardinelli L Wu L Fraser H Zygmunt AC Burashnikov A Diego JM Fish JM Cordeiro JM Goodrow RJ Jr. Scornik F Perez G Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent 2. J Cardiovasc Pharmacol Ther 2004 9 Suppl 1 S65 S83.
51. Antzelevitch C Belardinelli L Zygmunt AC Burashnikov A Di Diego JM Fish JM Cordeiro JM Thomas GP Electrophysiologic effects of ranolazine: A novel anti-anginal agent with antiarrhythmic properties. Circulation 2004 110 904 910.
52. Shimizu W McMahon B Antzelevitch C Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol 1999 10 156 164.
53. Sun ZQ Eddlestone GT Antzelevitch C Ionic mechanisms underlying the effects of sodium pentobarbital to diminish transmural dispersion of repolarization. Pacing Clin Electrophysiol 1997 20 11 1116 Abstract
54. Weissenburger J Nesterenko VV Antzelevitch C Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: Torsades de pointes develops with halothane but not pentobarbital anesthesia. J Cardiovasc Electrophysiol 2000 11 290 304.
55. Antzelevitch C Belardinelli L Wu L Fraser H Zygmunt AC Burashnikov A Di Diego JM Fish JM Cordeiro JM Goodrow RJ Scornik FS Perez GJ Electrophysiologic properties and antiarrhythmic actions of a novel anti-anginal agent. J Cardiovasc Pharmacol Ther 2004 9 Suppl 1 S65 S83.
56. Antzelevitch C Belardinelli L Wu L Fraser H Zygmunt AC Burashnikov A Di Diego JM Fish JM Cordeiro JM Goodrow RJ Scornik FS Perez GJ Electrophysiologic properties of ranolazine: A novel anti-anginal agent. J Cardiovasc Pharmacol Ther 2004 9 Suppl 1 S65 S83.
57. Shryock JC Song Y Wu L Fraser H Belardinelli L A mechanistic approach to assess the proarrhythmic risk of QT-prolonging drugs in preclinical pharmacologic studies. J Electrocardiol 2004 37 Suppl 34 39.
58. Antzelevitch C The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001 12 2 268 272.
59. Fish JM Antzelevitch C Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 2004 1 2 210 217.
60. Gussak I Antzelevitch C Bjerregaard P Towbin JA Chaitman BR The Brugada syndrome: Clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999 33 5 15.
61. Yan GX Antzelevitch C Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999 100 1660 1666.
62. Lukas A Antzelevitch C Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res 1996 32 593 603.
63. Antzelevitch C Brugada P Brugada J Brugada R Shimizu W Gussak I Perez Riera AR Brugada syndrome. A decade of progress. Circ Res 2002 91 12 1114 1119.
64. Kurita T Shimizu W Inagaki M Suyama K Taguchi A Satomi K Aihara N Kamakura S Kobayashi J Kosakai Y The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002 40 2 330 334.
65. Antzelevitch C Brugada P Borggrefe M Brugada J Brugada R Corrado D Gussak I LeMarec H Nademanee K Riera ARP Tan H Shimizu W Schultze-Bahr E Wilde A Brugada syndrome: Overview. In Antzelevitch C Brugada P Brugada J Brugada R eds. The Brugada Syndrome: From Bench to Bedside. Oxford Blackwell Futura 2004 pp. 1 22.
66. Dumaine R Towbin JA Brugada P Vatta M Nesterenko VV Nesterenko DV Brugada J Brugada R Antzelevitch C Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999 85 803 809.
67. Fish JM Welchons D Kim YS Ho WK Antzelevitch C Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006 in press
68. Antzelevitch C Shimizu W Yan GX Sicouri S Weissenburger J Nesterenko VV Burashnikov A Di Diego JM Saffitz JE Thomas GP The M cell. Its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999 10 1124 1152.